Association of Reproductive Health Professionals
Association of Reproductive Health Professionals
Reproductive Health Topics Publications & Resources Professional Education Newsroom Membership Policy & Advocacy About Us
CME/CE Opportunities - By FORMAT
Send To A Friend Send To A Friend Bookmark this Page Share this page
Webinars

Provider Education and Training to Increase Use of Intrauterine Contraception




This is an internet-based activity that should take 1 hour to complete. To receive CME/CE, learners should: 1) take the pre-test, 2) listen to the webinar, and 3) take the post-test.

Learning Objectives

At the conclusion of this presentation, participants should be able to:

  • Explain the differences between the three forms of intrauterine contraception available in the United States
  • Select appropriate candidates for intrauterine contraception
  • Describe two possible side effects of each type of intrauterine contraceptive
  • Describe pain management strategies during and after intrauterine contraception  insertion
  • Discuss strategies for follow-up of intrauterine contraceptive users

Accreditation Information

Physicians: The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this educational activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners and Nurses: This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour, including up to 0.5 pharmacology hours. Credit can be applied toward the nursing continuing education requirements of most professional organizations and State Boards of Nursing.

Others: A certificate of attendance will be issued indicating that this activity is accredited for a maximum of 1 hour of AMA PRA Category 1 CreditTM.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

This project is funded through educational grants from Teva Pharmaceuticals and Bayer HealthCare Pharmaceuticals.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Target Audience

The intended audiences for this activity are members of the primary care team who provide health services and education to menopausal women, including physicians, nurse practitioners, physician assistants, nurses and support staff who work in obstetrics/gynecology, family medicine, internal medicine and related settings.

Disclosures

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

  • Linda Dominguez, RN-C, NP (Planner) - Speaker for Teva Pharmaceutical, Bayer HealthCare Pharmaceuticals, and Merck & Co.
  • Mark Hathaway, MD, MPH (Course Director) - Consultant for Bayer HealthCare; Speaker for Pharmaceuticals and Merck & Co.
  • Barbara Clark, MPAS, PA-C (Planner), Carole Chrvala, PhD (Medical Writer), Aleya Horn Kennedy, MPP (ARHP Program Manager), Beth Jordan Mynett, MD (ARHP Medical Director), Amy Swann, MA, CAE (Vice President), have nothing to disclose.

Back